Plasma Concentrations of High Mobility Group Box 1 Proteins and Soluble Receptors for Advanced Glycation End-Products Are Relevant Biomarkers of Cognitive Impairment in Alcohol Use Disorder: A Pilot Study.

Journal: Toxics

Volume: 12

Issue: 3

Year of Publication: 

Affiliated Institutions:  Instituto de Investigación Biomédica de Málaga y Plataforma en Nanomedicina-IBIMA Plataforma BIONAND, Málaga, Spain. Department of Chemistry and Environmental Sciences, New Jersey Institute of Technology, Tiernan Hall , Newark, NJ , USA.

Abstract summary 

Alcohol use disorder (AUD) is a major component in the etiology of cognitive decline and dementia. Underlying mechanisms by which long-term alcohol abuse causes cognitive dysfunction include excessive oxidative stress and inflammation in the brain, activated by increased reactive oxygen/nitrogen species (ROS/RNS), advanced glycation end-products (AGEs) and high-mobility group box 1 protein (HMGB1). In a pilot study, we examine the potential clinical value of circulating biomarkers of oxidative stress including ROS/RNS, HMGB1, the soluble receptor for AGE (sRAGE), the brain biomarker of aging apolipoprotein D (ApoD), and the antioxidant regulator nuclear factor erythroid 2-related factor 2 (NRF2) as predictive indices for cognitive impairment (CI) in abstinent patients with AUD ( = 25) compared to patients with established Alzheimer's disease (AD, = 26) and control subjects ( = 25). Plasma concentrations of sRAGE were evaluated with immunoblotting; ROS/RNS with a fluorometric kit; and HMGB1, ApoD, and NRF2 by ELISA. Abstinent AUD patients had higher sRAGE, ROS/RNS ( < 0.05), and ApoD ( < 0.01) concentrations, similar to those of AD patients, and lower NRF2 ( < 0.01) concentrations, compared to controls. These changes were remarkable in AUD patients with CI. HMGB1, and sRAGE correlated positively with duration of alcohol use (rho = 0.398, = 0.022; rho = 0.404, = 0.018), whereas sRAGE correlated negatively with periods of alcohol abstinence (rho = -0.340, = 0.045). A predictive model including ROS/RNS, HMGB1, sRAGE, alcohol use duration, and alcohol abstinence periods was able to differentiate AUD patients with CI (92.3% of correct predictions, ROC-AUC= 0.90) from those without CI. In conclusion, we propose ROS/RNS, HMGB1, and sRAGE as stress biomarkers capable of predicting cognitive impairment in AUD patients.

Authors & Co-authors:  Rodríguez de Fonseca Medina-Paz Sapozhnikov Hurtado-Guerrero Rubio Martín-de-Las-Heras Requena-Ocaña Flores-López Fernández-Arjona Rivera Serrano Serrano C Zapico Suárez

Study Outcome 

Source Link: Visit source

Statistics
Citations :  NIAAA Alcohol Facts and Statistics. The National Institute on Alcohol Abuse and Alcoholism. [(accessed on 25 September 2023)]; Available online: https://www.niaaa.nih.gov/sites/default/files/AlcoholFactsAndStats.pdf.
Authors :  14
Identifiers
Doi : 190
SSN : 2305-6304
Study Population
Male,Female
Mesh Terms
Other Terms
Alzheimer’s disease;HMGB1;addiction;advanced glycation end-products;alcohol use disorder;apolipoprotein D;cognitive impairment;dementia;oxidative stress
Study Design
Study Approach
Country of Study
Publication Country
Switzerland